The Naloxone Delivery Cascade

Opioid overdose is among the leading causes of injury death in the United States. Naloxone is essential in overdose prevention. A recent study featuring PISC External Advisory Board Member Ricky Bluthenthal, PhD, evaluates the effect delivery and distribution of naloxone has on people who inject drugs. Results indicate that almost 72% of people who inject drugs have ever received naloxone. However, white PWID were more likely to receive naloxone than Black and Latinx PWID. Additionally, housed PWID were proven to be more likely to possess naloxone than unhoused PWID. Bluthenthal and the team conclude, “Naloxone scale-up should engage populations facing inequitable access, including people of color and those experiencing homelessness.”

Go to Article

Back to News